The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat
ContributorsRaposinho, Paula; White, R B; Aubert, Michel
Published inJournal of neuroendocrinology, vol. 15, no. 2, p. 173-181
Publication date2003
Abstract
Keywords
- Adipocytes/physiology
- Adipose Tissue/anatomy & histology
- Animals
- Carrier Proteins/physiology
- Drinking/drug effects
- Drug Interactions
- Eating/drug effects
- Gene Expression/drug effects
- Gonadal Steroid Hormones/physiology
- Growth Hormone-Releasing Hormone/genetics
- Hypothalamus/drug effects/physiology
- Insulin/blood
- Insulin-Like Growth Factor I/genetics/metabolism
- Intracellular Signaling Peptides and Proteins
- Leptin/blood
- Male
- Neuropeptide Y/genetics/pharmacology
- Neuropeptides/physiology
- Obesity/physiopathology
- Peptides, Cyclic/pharmacology
- Pro-Opiomelanocortin/genetics
- Rats
- Rats, Sprague-Dawley
- Weight Gain/drug effects
- Alpha-MSH/agonists/analogs & derivatives/pharmacology
Citation (ISO format)
RAPOSINHO, Paula, WHITE, R B, AUBERT, Michel. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. In: Journal of neuroendocrinology, 2003, vol. 15, n° 2, p. 173–181. doi: 10.1046/j.1365-2826.2003.00962.x
Main files (1)
Article (Published version)
Identifiers
- PID : unige:55261
- DOI : 10.1046/j.1365-2826.2003.00962.x
- PMID : 12535159
ISSN of the journal0953-8194